Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

SB 1098 requires Texas pharmacies to disclose the lowest cash price for a prescribed drug or biological product to patients. If the cash price is lower than the patient's insurance copayment, pharmacists must offer the option to pay the lower cash price instead of the copayment amount. This directly affects patients filling prescriptions, particularly those with insurance plans where copayments exceed cash prices. The law takes effect September 1, 2025, aiming to increase prescription price transparency and give patients cost-saving options.